# LOUIS STOKES CLEVELAND VA MEDICAL CENTER: Targeting Hexosamine Biosynthetic Pathway and O-GlcNAcylation to Treat Acute Myeloid Leukemia

**Lab Budget Score:** 30/100

| Field | Value |
|---|---|
| Organization | LOUIS STOKES CLEVELAND VA MEDICAL CENTER |
| Location | CLEVELAND, OH |
| Project | Targeting Hexosamine Biosynthetic Pathway and O-GlcNAcylation to Treat Acute Myeloid Leukemia |
| Project number | 5I01BX005941-03 |
| Mechanism | I01 |
| Institute | Veterans Affairs |
| Awarded | 2026-10-22 |
| Project period | 2024-07-01 to 2028-06-30 |
| UEI | KHM6GRQMTKL1 |

## Why this score
- Awarded in the last 30 days.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11399497). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.